Sign in Subscribe
United States. Securities and Exchange Commission

Bluebird Bio, Inc. Submits SEC Form 8-K with 12 Filed Documents

Strategic Insights

— 1 min read

Bluebird Bio, Inc. has recently submitted a U.S. Securities and Exchange Commission (SEC) filing, specifically a Form 8-K, which is a "current report" used to document material events or corporate changes important to investors or security holders. The filing was made on December 29, 2022, and contains 12 documents. This report is more current than forms 10-Q or 10-K and provides information on significant events not previously reported.

Key Takeaways:

  • Bluebird Bio, Inc. submitted a SEC Form 8-K filing on December 29, 2022, containing 12 documents.
  • The filing provides more current information on significant events than Form 10-Q or 10-K reports.
  • The SIC code for Bluebird Bio, Inc. is 2836, Biological Products (No Diagnostic Substances).
  • The company's contact information is 455 Grand Union Boulevard, Somerville, MA 02145, with a phone number of 339-499-9300.
  • Bluebird Bio, Inc. is a biotechnology company that focuses on healthcare-related developments.
  • The SEC filing is a formal document submitted to report significant corporate changes or material events.
  • Bluebird Bio, Inc. operates in the biotechnology industry, specifically in the area of biological products development.

Statistics:

  • Date of SEC Form 8-K filing: December 29, 2022.
  • Number of documents filed: 12.
  • SIC code: 2836.
  • Company contact information: 455 Grand Union Boulevard, Somerville, MA 02145, 339-499-9300.
  • Number of filings: 1 (Form 8-K).
  • Industry: Healthcare Biotechnology Companies.

Sources:

  • SEC filing - https://www.sec.gov/Archives/edgar/data/1293971/0001193125-22-314755-index.html.
  • Bluebird Bio, Inc. - 455 Grand Union Boulevard, Somerville, MA 02145, 339-499-9300.
  • SEC Form 8-K - U.S. Securities and Exchange Commission.

Read more